Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cyslabdan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Bioinformatic mining of the Streptomyces thermocarboxydus K155 genome predicted the presence of four synthases for the production… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2016
Review
2016
  • H. Tomoda
  • Chemical & pharmaceutical bulletin
  • 2016
  • Corpus ID: 207176506
Methicillin-resistant Staphylococuss aureus (MRSA) is a major nosocomial pathogen that has developed resistance to many… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
Cyslabdan was isolated from the culture broth of Streptomyces sp. K04-0144 as a new potentiator of imipenem activity against… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
2016
2016
Methicillin-resistant Staphylococuss aureus (MRSA) is a major nosocomial pathogen that has developed resistance to many… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2015
2015
Genome mining of cyslabdan-producing Streptomycescyslabdanicus K04-0144 revealed that a set of four genes, cldA, cldB, cldC, and… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2014
2014
Actinomycete strains OM-6519T and K04–0144T produce the bioactive compounds lactacystin and cyslabdan, respectively. Here, the… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2012
2012
The nonantibiotic small molecule cyslabdan, a labdan-type diterpene produced by Streptomyces sp. K04-0144, markedly potentiated… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Review
2012
Review
2012
  • H. Tomoda
  • Yakugaku zasshi : Journal of the Pharmaceutical…
  • 2012
  • Corpus ID: 39589030
Methicillin-resistant Staphylococcus aureus (MRSA) is known as a major nosocomial pathogen that has also developed resistance to… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2008
2008
AbstractCyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, was isolated from… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2008
2008
AbstractCyslabdan produced by Streptomyces sp. K04-0144 was found to potentiate imipenem activity against methicillin-resistant… Expand
  • figure 1
  • table 1
  • table 3
  • table 2